Literature DB >> 36048186

[Role of the gut microbiome in the development and transfer of antibiotic resistances].

Tobias M Appel1, Maria J Vehreschild2.   

Abstract

Antimicrobial resistance (AR) is a natural phenomenon resulting from the exposure of bacteria to antibacterial substances. The intestinal microbiome plays a central role in the development and transmission of AR. In its physiological state, the intestinal microbiome has several mechanisms that contribute to what is referred to as colonization resistance against potentially pathogenic and often multiresistant bacteria. Exposure to broad-spectrum antibiotics can disrupt those mechanisms, facilitating colonization with these pathogens. The persistence of antibiotic selection pressure favors growth of multiresistant bacteria and their dominance within the intestinal microbiota. Under these circumstances, the risk of the development of invasive infections increases. Antibiotic stewardship programs, the use of narrow-spectrum antibiotics, and the administration of substances that protect the intestinal microbiome from antibiotic exposure can prevent these processes. Several interventions such as the administration of probiotics, oral antibiotics, and fecal microbiome transfers are potential strategies for decolonizing patients with multidrug resistant bacteria; to date, however, no intervention has been proven to be consistently effective.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Anti-bacterial agents, broad-spectrum; Anti-bacterial agents, narrow-spectrum; Antibiotic Stewardship; Drug resistance, multiple; Gene transfer, horizontal

Year:  2022        PMID: 36048186     DOI: 10.1007/s00108-022-01400-1

Source DB:  PubMed          Journal:  Inn Med (Heidelb)        ISSN: 2731-7080


  22 in total

1.  Sampling the antibiotic resistome.

Authors:  Vanessa M D'Costa; Katherine M McGrann; Donald W Hughes; Gerard D Wright
Journal:  Science       Date:  2006-01-20       Impact factor: 47.728

Review 2.  Intestinal colonization resistance.

Authors:  Trevor D Lawley; Alan W Walker
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

3.  E. coli enhance colonization resistance against Salmonella Typhimurium by competing for galactitol, a context-dependent limiting carbon source.

Authors:  Claudia Eberl; Anna S Weiss; Lara M Jochum; Abilash Chakravarthy Durai Raj; Diana Ring; Saib Hussain; Simone Herp; Chen Meng; Karin Kleigrewe; Michael Gigl; Marijana Basic; Bärbel Stecher
Journal:  Cell Host Microbe       Date:  2021-10-04       Impact factor: 21.023

4.  Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition.

Authors:  Lisa Osbelt; Marie Wende; Éva Almási; Elisabeth Derksen; Uthayakumar Muthukumarasamy; Till R Lesker; Eric J C Galvez; Marina C Pils; Enrico Schalk; Patrick Chhatwal; Jacqueline Färber; Meina Neumann-Schaal; Thomas Fischer; Dirk Schlüter; Till Strowig
Journal:  Cell Host Microbe       Date:  2021-10-04       Impact factor: 21.023

Review 5.  Colonization resistance against multi-drug-resistant bacteria: a narrative review.

Authors:  R Le Guern; S Stabler; P Gosset; M Pichavant; T Grandjean; E Faure; Y Karaca; K Faure; E Kipnis; R Dessein
Journal:  J Hosp Infect       Date:  2021-09-04       Impact factor: 3.926

6.  A new genomic blueprint of the human gut microbiota.

Authors:  Alexandre Almeida; Alex L Mitchell; Miguel Boland; Samuel C Forster; Gregory B Gloor; Aleksandra Tarkowska; Trevor D Lawley; Robert D Finn
Journal:  Nature       Date:  2019-02-11       Impact factor: 49.962

7.  Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.

Authors:  Benedikt Huttner; Thomas Haustein; Ilker Uçkay; Gesuele Renzi; Andrew Stewardson; Danièle Schaerrer; Americo Agostinho; Antoine Andremont; Jacques Schrenzel; Didier Pittet; Stephan Harbarth
Journal:  J Antimicrob Chemother       Date:  2013-05-29       Impact factor: 5.790

8.  Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae.

Authors:  Isabel Machuca; Belén Gutiérrez-Gutiérrez; Salvador Pérez Cortés; Irene Gracia-Ahufinger; Josefina Serrano; María Dolores Madrigal; José Barcala; Fernando Rodríguez-López; Jesús Rodríguez-Baño; Julián Torre-Cisneros
Journal:  J Antimicrob Chemother       Date:  2016-07-26       Impact factor: 5.790

9.  Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification.

Authors:  Matthew T Sorbara; Krista Dubin; Eric R Littmann; Thomas U Moody; Emily Fontana; Ruth Seok; Ingrid M Leiner; Ying Taur; Jonathan U Peled; Marcel R M van den Brink; Yael Litvak; Andreas J Bäumler; Jean-Luc Chaubard; Amanda J Pickard; Justin R Cross; Eric G Pamer
Journal:  J Exp Med       Date:  2018-12-18       Impact factor: 14.307

Review 10.  Antimicrobial stewardship: another focus for patient safety?

Authors:  Pranita D Tamma; Alison Holmes; Elizabeth Dodds Ashley
Journal:  Curr Opin Infect Dis       Date:  2014-08       Impact factor: 4.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.